Drugmaker dismisses former research boss from role at Galvani Bioelectronics
GSK has dismissed its former research boss Moncef Slaoui, who became US national vaccine chief under Donald Trump, after an independent investigation found that he sexually harassed one of its female employees.
GSK said it had terminated Slaoui’s role at Galvani Bioelectronics, a joint venture majority owned by GSK, with immediate effect. Slaoui had until January led the US vaccine programme Operation Warp Speed.
